Product Description A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease. MOQ: 1 piece delivery time : within 3-5 days delivery terms : DHL,EMS ,FEDEX and so on . After sale : online 24h Tirzepatide GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide, Retatrutide.
Looks like there are no reviews for this Product
Looks like there are no reviews for this product
China
We are a manufacturer and exporter of dermal fillers and a wide range of beauty and aesthetic products. As a dermal filler producer, we ensure high-quality standards, safety, and consistency across all our products for international markets.
China
A virtual marketplace leading your business into the future
